# Kratos Defense & Security Solutions, Inc.: financial statements, quarterly

KTOS · Nasdaq · CIK 1069258 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 27

Pages: [Overview](/companies/ktos.md) · [Financials](/companies/ktos/financials.md) · [Filings](/companies/ktos/filings.md) · [Insiders](/companies/ktos/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/ktos/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-10-01) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-29) | Q4 FY2024 (2024-12-29) | Q1 FY2025 (2025-03-30) | Q2 FY2025 (2025-06-29) | Q3 FY2025 (2025-09-28) | Q4 FY2025 (2025-12-28) | Q1 FY2026 (2026-03-29) | Q2 FY2026 (2026-06-28) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [275](/filings/0001069258-24-000061.md) | [274 d](/filings/0001069258-26-000013.md) | [277](/filings/0001069258-25-000028.md) | [300](/filings/0001069258-25-000048.md) | [276](/filings/0001069258-25-000058.md) | [283 d](/filings/0001069258-26-000013.md) | [303](/filings/0001069258-26-000053.md) | [352](/filings/0001069258-26-000077.md) | [348](/filings/0001069258-25-000058.md) | [345 d](/filings/0001069258-26-000013.md) | [371](/filings/0001069258-26-000053.md) | [459](/filings/0001069258-26-000077.md) |
| Cost of revenue | $m | [201](/filings/0001069258-24-000061.md) | [202 d](/filings/0001069258-26-000013.md) | [206](/filings/0001069258-25-000028.md) | [223](/filings/0001069258-25-000048.md) | [207](/filings/0001069258-25-000058.md) | [213 d](/filings/0001069258-26-000013.md) | [229](/filings/0001069258-26-000053.md) | [278](/filings/0001069258-26-000077.md) | [271](/filings/0001069258-25-000058.md) | [262 d](/filings/0001069258-26-000013.md) | [281](/filings/0001069258-26-000053.md) | [359](/filings/0001069258-26-000077.md) |
| Gross profit | $m | [73.4](/filings/0001069258-24-000061.md) | [71.9 d](/filings/0001069258-26-000013.md) | [71.0](/filings/0001069258-25-000028.md) | [77.2](/filings/0001069258-25-000048.md) | [69.2](/filings/0001069258-25-000058.md) | [69.8 d](/filings/0001069258-26-000013.md) | [73.6](/filings/0001069258-26-000053.md) | [73.8](/filings/0001069258-26-000077.md) | [77.1](/filings/0001069258-25-000058.md) | [83.4 d](/filings/0001069258-26-000013.md) | [89.6](/filings/0001069258-26-000053.md) | [100](/filings/0001069258-26-000077.md) |
| Research and development | $m | [10.3](/filings/0001069258-24-000061.md) | [8.0 d](/filings/0001069258-26-000013.md) | [9.6](/filings/0001069258-25-000028.md) | [10.2](/filings/0001069258-25-000048.md) | [9.9](/filings/0001069258-25-000058.md) | [10.6 d](/filings/0001069258-26-000013.md) | [10.0](/filings/0001069258-26-000053.md) | [10.2](/filings/0001069258-26-000077.md) | [10.0](/filings/0001069258-25-000058.md) | [9.8 d](/filings/0001069258-26-000013.md) | [10.7](/filings/0001069258-26-000053.md) | [13.6](/filings/0001069258-26-000077.md) |
| Selling, general and administrative | $m | [50.9](/filings/0001069258-24-000061.md) | [52.7 d](/filings/0001069258-26-000013.md) | [54.4](/filings/0001069258-25-000028.md) | [54.5](/filings/0001069258-25-000048.md) | [52.6](/filings/0001069258-25-000058.md) | [55.7 d](/filings/0001069258-26-000013.md) | [57.0](/filings/0001069258-26-000053.md) | [59.9](/filings/0001069258-26-000077.md) | [59.8](/filings/0001069258-25-000058.md) | [63.5 d](/filings/0001069258-26-000013.md) | [72.3](/filings/0001069258-26-000053.md) | [87.3](/filings/0001069258-26-000077.md) |
| Operating income | $m | [12.2](/filings/0001069258-24-000061.md) | [11.7 d](/filings/0001069258-26-000013.md) | [7.0](/filings/0001069258-25-000028.md) | [12.5](/filings/0001069258-25-000048.md) | [6.5](/filings/0001069258-25-000058.md) | [3.0 d](/filings/0001069258-26-000013.md) | [6.6](/filings/0001069258-26-000053.md) | [3.7](/filings/0001069258-26-000077.md) | [7.1](/filings/0001069258-25-000058.md) | [8.2 d](/filings/0001069258-26-000013.md) | [4.7](/filings/0001069258-26-000053.md) | [(1.6)](/filings/0001069258-26-000077.md) |
| Income tax | $m | [3.8](/filings/0001069258-24-000061.md) | [2.0 d](/filings/0001069258-26-000013.md) | [2.7](/filings/0001069258-25-000028.md) | [4.8](/filings/0001069258-25-000048.md) | [2.6](/filings/0001069258-25-000058.md) | [0.1 d](/filings/0001069258-26-000013.md) | [0.9](/filings/0001069258-26-000053.md) | [1.7](/filings/0001069258-26-000077.md) | [3.2](/filings/0001069258-25-000058.md) | [6.2 d](/filings/0001069258-26-000013.md) | [(2.1)](/filings/0001069258-26-000053.md) | [2.6](/filings/0001069258-26-000077.md) |
| Net income | $m | [(1.6)](/filings/0001069258-24-000061.md) | [2.4 d](/filings/0001069258-26-000013.md) | [1.3](/filings/0001069258-25-000028.md) | [7.9](/filings/0001069258-25-000048.md) | [3.2](/filings/0001069258-25-000058.md) | [3.9 d](/filings/0001069258-26-000013.md) | [4.5](/filings/0001069258-26-000053.md) | [2.9](/filings/0001069258-26-000077.md) | [8.7](/filings/0001069258-25-000058.md) | [5.9 d](/filings/0001069258-26-000013.md) | [11.9](/filings/0001069258-26-000053.md) | [4.4](/filings/0001069258-26-000077.md) |
| Diluted EPS | $ per share | [(0.01)](/filings/0001069258-24-000061.md) | not reported | [0.01](/filings/0001069258-25-000028.md) | [0.05](/filings/0001069258-25-000048.md) | [0.02](/filings/0001069258-25-000058.md) | not reported | [0.03](/filings/0001069258-26-000053.md) | [0.02](/filings/0001069258-26-000077.md) | [0.05](/filings/0001069258-25-000058.md) | not reported | [0.07](/filings/0001069258-26-000053.md) | [0.02](/filings/0001069258-26-000077.md) |
| Basic EPS | $ per share | [(0.01)](/filings/0001069258-24-000061.md) | not reported | [0.01](/filings/0001069258-25-000028.md) | [0.05](/filings/0001069258-25-000048.md) | [0.02](/filings/0001069258-25-000058.md) | not reported | [0.03](/filings/0001069258-26-000053.md) | [0.02](/filings/0001069258-26-000077.md) | [0.05](/filings/0001069258-25-000058.md) | not reported | [0.07](/filings/0001069258-26-000053.md) | [0.02](/filings/0001069258-26-000077.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-10-01) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-29) | FY2024 (2024-12-29) | Q1 FY2025 (2025-03-30) | Q2 FY2025 (2025-06-29) | Q3 FY2025 (2025-09-28) | FY2025 (2025-12-28) | Q1 FY2026 (2026-03-29) | Q2 FY2026 (2026-06-28) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [42.2](/filings/0001069258-23-000062.md) | [72.8](/filings/0001069258-25-000008.md) | [339](/filings/0001069258-24-000036.md) | [308](/filings/0001069258-24-000051.md) | [302](/filings/0001069258-24-000061.md) | [329](/filings/0001069258-26-000013.md) | [264](/filings/0001069258-25-000028.md) | [784](/filings/0001069258-25-000048.md) | [566](/filings/0001069258-25-000058.md) | [561](/filings/0001069258-26-000077.md) | [1,464](/filings/0001069258-26-000053.md) | [1,438](/filings/0001069258-26-000077.md) |
| Current assets | $m | [604](/filings/0001069258-23-000062.md) | [594](/filings/0001069258-25-000008.md) | [872](/filings/0001069258-24-000036.md) | [851](/filings/0001069258-24-000051.md) | [838](/filings/0001069258-24-000061.md) | [872](/filings/0001069258-26-000013.md) | [864](/filings/0001069258-25-000028.md) | [1,429](/filings/0001069258-25-000048.md) | [1,237](/filings/0001069258-25-000058.md) | [1,263](/filings/0001069258-26-000077.md) | [2,310](/filings/0001069258-26-000053.md) | [2,357](/filings/0001069258-26-000077.md) |
| Total assets | $m | [1,591](/filings/0001069258-23-000062.md) | [1,633](/filings/0001069258-25-000008.md) | [1,951](/filings/0001069258-25-000028.md) | [1,914](/filings/0001069258-24-000051.md) | [1,912](/filings/0001069258-24-000061.md) | [1,951](/filings/0001069258-26-000013.md) | [2,005](/filings/0001069258-25-000028.md) | [2,586](/filings/0001069258-25-000048.md) | [2,423](/filings/0001069258-25-000058.md) | [2,467](/filings/0001069258-26-000077.md) | [4,043](/filings/0001069258-26-000053.md) | [4,090](/filings/0001069258-26-000077.md) |
| Current liabilities | $m | [263](/filings/0001069258-23-000062.md) | [293](/filings/0001069258-25-000008.md) | [288](/filings/0001069258-24-000036.md) | [272](/filings/0001069258-24-000051.md) | [261](/filings/0001069258-24-000061.md) | [297](/filings/0001069258-26-000013.md) | [305](/filings/0001069258-25-000028.md) | [322](/filings/0001069258-25-000048.md) | [287](/filings/0001069258-25-000058.md) | [311](/filings/0001069258-26-000077.md) | [411](/filings/0001069258-26-000053.md) | [425](/filings/0001069258-26-000077.md) |
| Total liabilities | $m | [618](/filings/0001069258-23-000062.md) | [634](/filings/0001069258-25-000008.md) | [586](/filings/0001069258-24-000036.md) | [585](/filings/0001069258-24-000051.md) | [570](/filings/0001069258-24-000061.md) | [598](/filings/0001069258-26-000013.md) | [617](/filings/0001069258-25-000028.md) | [626](/filings/0001069258-25-000048.md) | [442](/filings/0001069258-25-000058.md) | [471](/filings/0001069258-26-000077.md) | [633](/filings/0001069258-26-000053.md) | [663](/filings/0001069258-26-000077.md) |
| Long-term debt | $m | [234](/filings/0001069258-23-000062.md) | [219](/filings/0001069258-25-000008.md) | [179](/filings/0001069258-24-000036.md) | [180](/filings/0001069258-24-000051.md) | [177](/filings/0001069258-24-000061.md) | [175](/filings/0001069258-26-000013.md) | [172](/filings/0001069258-25-000028.md) | [170](/filings/0001069258-25-000048.md) | [0.0](/filings/0001069258-25-000058.md) | [0.0](/filings/0001069258-26-000013.md) | not reported | not reported |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [953](/filings/0001069258-24-000061.md) | [976](/filings/0001069258-25-000058.md) | [1,306](/filings/0001069258-25-000048.md) | [1,329](/filings/0001069258-25-000058.md) | [1,343](/filings/0001069258-25-000058.md) | [1,353](/filings/0001069258-26-000077.md) | [1,388](/filings/0001069258-26-000077.md) | [1,960](/filings/0001069258-26-000077.md) | [1,982](/filings/0001069258-25-000058.md) | [1,996](/filings/0001069258-26-000077.md) | [3,410](/filings/0001069258-26-000077.md) | [3,427](/filings/0001069258-26-000077.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest, us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-10-01) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-29) | Q4 FY2024 (2024-12-29) | Q1 FY2025 (2025-03-30) | Q2 FY2025 (2025-06-29) | Q3 FY2025 (2025-09-28) | Q4 FY2025 (2025-12-28) | Q1 FY2026 (2026-03-29) | Q2 FY2026 (2026-06-28) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [0.0 d](/filings/0001069258-24-000061.md) | [67.4 d](/filings/0001069258-26-000013.md) | [0.7](/filings/0001069258-25-000028.md) | [(2.7) d](/filings/0001069258-25-000048.md) | [6.1 d](/filings/0001069258-25-000058.md) | [45.6 d](/filings/0001069258-26-000013.md) | [(29.2)](/filings/0001069258-26-000053.md) | [(11.7) d](/filings/0001069258-26-000077.md) | [(13.3) d](/filings/0001069258-25-000058.md) | [12.1 d](/filings/0001069258-26-000013.md) | [(27.4)](/filings/0001069258-26-000053.md) | [(11.0) d](/filings/0001069258-26-000077.md) |
| Capital expenditure | $m | [14.2 d](/filings/0001069258-24-000061.md) | [19.3 d](/filings/0001069258-26-000013.md) | [16.6](/filings/0001069258-25-000028.md) | [12.7 d](/filings/0001069258-25-000048.md) | [15.3 d](/filings/0001069258-25-000058.md) | [13.6 d](/filings/0001069258-26-000013.md) | [22.6](/filings/0001069258-26-000053.md) | [20.5 d](/filings/0001069258-26-000077.md) | [28.0 d](/filings/0001069258-25-000058.md) | [24.2 d](/filings/0001069258-26-000013.md) | [19.9](/filings/0001069258-26-000053.md) | [17.2 d](/filings/0001069258-26-000077.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-25) | Q1 FY2023 (2023-03-26) | Q2 FY2023 (2023-06-25) | Q3 FY2023 (2023-10-01) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-29) | Q1 FY2025 (2025-03-30) | Q2 FY2025 (2025-06-29) | Q3 FY2025 (2025-09-28) | Q1 FY2026 (2026-03-29) | Q2 FY2026 (2026-06-28) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [127](/filings/0001069258-23-000062.md) | [128](/filings/0001069258-24-000036.md) | [129](/filings/0001069258-24-000051.md) | [130](/filings/0001069258-24-000061.md) | [142](/filings/0001069258-25-000028.md) | [154](/filings/0001069258-25-000048.md) | [154](/filings/0001069258-25-000058.md) | [156](/filings/0001069258-26-000053.md) | [157](/filings/0001069258-26-000077.md) | [173](/filings/0001069258-25-000058.md) | [179](/filings/0001069258-26-000053.md) | [190](/filings/0001069258-26-000077.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 187,721,327 at 2026-07-31, from the cover of the [10-Q filed 2026-08-04](/filings/0001069258-26-000077.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:32 ET. No prices; not investment advice.